- Home
- CRVS vs CAN Comparison
CRVS vs CAN Comparison
Compare CRVS & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- CAN
- Stock Information
- Founded
- CRVS 2014
- CAN 2013
- Country
- CRVS United States
- CAN Singapore
- Employees
- CRVS N/A
- CAN N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- CAN Semiconductors
- Sector
- CRVS Health Care
- CAN Technology
- Exchange
- CRVS Nasdaq
- CAN Nasdaq
- Market Cap
- CRVS 516.0M
- CAN 425.9M
- IPO Year
- CRVS 2016
- CAN 2019
- Fundamental
- Price
- CRVS $4.99
- CAN $2.32
- Analyst Decision
- CRVS Buy
- CAN Strong Buy
- Analyst Count
- CRVS 4
- CAN 3
- Target Price
- CRVS $12.83
- CAN $3.00
- AVG Volume (30 Days)
- CRVS 1.6M
- CAN 25.7M
- Earning Date
- CRVS 11-12-2024
- CAN 11-20-2024
- Dividend Yield
- CRVS N/A
- CAN N/A
- EPS Growth
- CRVS N/A
- CAN N/A
- EPS
- CRVS N/A
- CAN N/A
- Revenue
- CRVS N/A
- CAN $229,630,000.00
- Revenue This Year
- CRVS N/A
- CAN $24.51
- Revenue Next Year
- CRVS N/A
- CAN $84.90
- P/E Ratio
- CRVS N/A
- CAN N/A
- Revenue Growth
- CRVS N/A
- CAN N/A
- 52 Week Low
- CRVS $1.30
- CAN $0.72
- 52 Week High
- CRVS $10.00
- CAN $3.50
- Technical
- Relative Strength Index (RSI)
- CRVS 28.00
- CAN 51.08
- Support Level
- CRVS $3.77
- CAN $2.62
- Resistance Level
- CRVS $7.44
- CAN $3.27
- Average True Range (ATR)
- CRVS 0.60
- CAN 0.39
- MACD
- CRVS -0.41
- CAN -0.06
- Stochastic Oscillator
- CRVS 25.85
- CAN 26.36
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment as well as the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts.